Baird Medical Investment Holdings (BDMD) Liabilities and Shareholders Equity (2023 - 2025)

Baird Medical Investment Holdings' Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $69.7 million for Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity fell 10.6% year-over-year to $69.7 million; the TTM figure through Dec 2025 stood at $224.7 million (changed N/A YoY), while the FY2025 annual figure was $69.7 million, down 10.6% from the prior year.
• Liabilities and Shareholders Equity was $69.7 million for Q4 2025 at Baird Medical Investment Holdings, down from $77.0 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $78.0 million in Q4 2024 to a low of $56.7 million in Q4 2023.
• Historically, Liabilities and Shareholders Equity has averaged $70.3 million across 3 years, with a median of $73.3 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity surged 37.48% in 2024, then declined 10.6% in 2025.
• A 3-year view of Liabilities and Shareholders Equity shows it stood at $56.7 million in 2023, then jumped by 37.48% to $78.0 million in 2024, then retreated by 10.6% to $69.7 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $69.7 million (Q4 2025), $77.0 million (Q2 2025), and $78.0 million (Q4 2024), per Business Quant data.